Table 1.
Demographic data and concomitant medications.
| Demographics | Mean | (SD) |
|---|---|---|
| Age (years) | 45.66 | (9.15) |
| Sex (percent female) | 75% | |
| Racea | ||
| Body mass index | 28.86 | (6.44) |
| Duration of MS (years) | 7.45 | (6.96) |
| Expanded Disability Severity Scale (EDSS) | 2.72 | (1.75) |
| Concomitant medications |
No. of patients | |
| Antidepressants for mood | 11/32 | |
| Antidepressants for insomnia | 4/32 | |
| Benzodiazepines | 6/32 | |
| Anti-epileptic drugs (gabapentin) | 3/32 | |
| Wake-promoting agents | 10/32 | |
| Non-benzodiazepine hypnotics | 4/32 | |
| Dopamine agonists | 1/32 | |
| No concomitant medications | 6/32 |
MS: multiple sclerosis; SD: standard deviation.
Values are mean (SD).
aRace: 27/32 White, 3/32 African-American and 2/32 Hispanic.